What Happened?
Ann Arbor, MI-based BlueWillow-Biologics Appointed David Peralta as Chief Executive Officer
About the Company
NanoBio® is a division of BlueWillow Biologics, Inc., a privately-held biopharmaceutical company focused on developing intranasal vaccines and topical anti-infective therapies based on its patented nanotechnology platform.
About the Person
David Peralta is Chief Executive Officer at BlueWillow Biologics. Previously, David held various senior HR leadership roles in the industry.
Info Source
News
Short Profile